Compass Therapeutics, Inc.
CMPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49,375 | -$42,494 | -$39,225 | -$82,181 |
| Dep. & Amort. | $1,753 | $1,890 | $1,904 | $1,624 |
| Deferred Tax | $0 | $0 | $0 | $50,576 |
| Stock-Based Comp. | $8,560 | $6,120 | $5,330 | $4,029 |
| Change in WC | -$4,142 | -$2,908 | -$1,263 | $6,245 |
| Other Non-Cash | -$1,651 | $5,966 | -$871 | $41 |
| Operating Cash Flow | -$44,855 | -$40,618 | -$34,125 | -$19,666 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$44 | -$30 | -$212 | -$1,568 |
| Net Acquisitions | $0 | $0 | $176 | $116 |
| Inv. Purchases | -$88,158 | -$155,418 | -$200,119 | $0 |
| Inv. Sales/Matur. | $134,974 | $182,413 | $48,955 | $0 |
| Other Inv. Act. | $0 | $27 | -$151 | -$318 |
| Investing Cash Flow | $46,772 | $26,965 | -$151,200 | -$1,770 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $18,113 | $3,094 | $76,237 | $128,267 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$775 | -$159 | -$480 | -$281 |
| Financing Cash Flow | $17,338 | $2,935 | $75,757 | $118,611 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $19,255 | -$10,718 | -$109,568 | $97,175 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24,228 | $34,946 | $144,514 | $47,339 |
| End Cash | $43,483 | $24,228 | $34,946 | $144,514 |
| Free Cash Flow | -$44,899 | -$40,648 | -$34,337 | -$21,234 |